|
1
|
World Health Organization: WHO Coronavirus
(COVID-19) Dashboard. https://covid19.who.int/. Accessed April 9, 2022.
|
|
2
|
The National Health Commission of China:
The diagnosis and treatment of COVID-19. http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml.
Accessed 1 April 2022, 2022.
|
|
3
|
Ferreira de Araújo JL, Menezes D, Saraiva
Duarte JM, de Lima Ferreira L, Santana de Aguiar R and Pedra de
Souza R: Systematic review of host genetic association with
Covid-19 prognosis and susceptibility: What have we learned in
2020? Rev Med Virol. 32(e2283)2022.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Suh S, Lee S, Gym H, Yoon S, Park S, Cha
J, Kwon DH, Yang Y and Jee SH: A systematic review on papers that
study on single nucleotide polymorphism that affects coronavirus
2019 severity. BMC Infect Dis. 22(47)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Brass AL, Huang IC, Benita Y, John SP,
Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig
E, et al: The IFITM proteins mediate cellular resistance to
influenza A H1N1 virus, West Nile virus, and dengue virus. Cell.
139:1243–1254. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Perreira JM, Chin CR, Feeley EM and Brass
AL: IFITMs restrict the replication of multiple pathogenic viruses.
J Mol Biol. 425:4937–4955. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ren L, Du S, Xu W, Li T, Wu S, Jin N and
Li C: Current progress on host antiviral factor IFITMs. Front
Immunol. 11(543444)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Everitt AR, Clare S, Pertel T, John SP,
Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, et al:
IFITM3 restricts the morbidity and mortality associated with
influenza. Nature. 484:519–523. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Prabhu SS, Chakraborty TT, Kumar N and
Banerjee I: Association between IFITM3 rs12252 polymorphism and
influenza susceptibility and severity: A meta-analysis. Gene.
674:70–79. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li
K, Liang L, Zhang C, Dai Y, Feng Y, et al: Interferon-induced
transmembrane protein 3 genetic variant rs12252-C associated with
disease severity in coronavirus disease 2019. J Infect Dis.
222:34–37. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pan Y, Li F, Wang X, Liang Z, Cui S, Peng
X, Lu G, Zhao J, Liu Y, Wang Q and Zhang D: Association between
rs12252 polymorphism in IFITM3 gene and COVID-19. Int J Virology.
28:192–195. 2021.
|
|
12
|
Alghamdi J, Alaamery M, Barhoumi T, Rashid
M, Alajmi H, Aljasser N, Alhendi Y, Alkhalaf H, Alqahtani H,
Algablan O, et al: Interferon-induced transmembrane protein-3
genetic variant rs12252 is associated with COVID-19 mortality.
Genomics. 113:1733–1741. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cuesta-Llavona E, Albaiceta GM,
García-Clemente M, Duarte-Herrera ID, Amado-Rodríguez L,
Hermida-Valverde T, Enríquez-Rodriguez AI, Hernández-González C,
Melón S, Alvarez-Argüelles ME, et al: Association between the
interferon-induced transmembrane protein 3 gene (IFITM3) rs34481144
/ rs12252 haplotypes and COVID-19. Curr Res Virol Sci.
2(100016)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Schönfelder K, Breuckmann K, Elsner C,
Dittmer U, Fistera D, Herbstreit F, Risse J, Schmidt K, Sutharsan
S, Taube C, et al: The influence of IFITM3 polymorphisms on
susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Cytokine. 142(155492)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle-Ottawa scale (NOS)
for assessing the quality of nonrandomised studies in
meta-analyses. Ottawa Hospital Research Institute, Ottawa, ON,
2000. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
|
|
16
|
Harbord RM, Harris RJ and Sterne JAC:
Updated tests for small-study effects in meta-analyses. Stata J.
9:197–210. 2009.
|
|
17
|
Stroup DF, Berlin JA, Morton SC, Olkin I,
Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker
SB: Meta-analysis of observational studies in epidemiology: A
proposal for reporting. Meta-analysis Of observational studies in
epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang YH, Zhao Y, Li N, Peng YC,
Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, et al:
Interferon-induced transmembrane protein-3 genetic variant
rs12252-C is associated with severe influenza in Chinese
individuals. Nat Commun. 4(1418)2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Randolph AG, Yip WK, Allen EK, Rosenberger
CM, Agan AA, Ash SA, Zhang Y, Bhangale TR, Finkelstein D,
Cvijanovich NZ, et al: Evaluation of IFITM3 rs12252 association
with severe pediatric influenza infection. J Infect Dis. 216:14–21.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
López-Rodríguez M, Herrera-Ramos E,
Solé-Violán J, Ruíz-Hernández JJ, Borderías L, Horcajada JP,
Lerma-Chippirraz E, Rajas O, Briones M, Pérez-González MC, et al:
IFITM3 and severe influenza virus infection. No evidence of genetic
association. Eur J Clin Microbiol Infect Dis. 35:1811–1817.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Prelli Bozzo C, Nchioua R, Volcic M,
Koepke L, Krüger J, Schütz D, Heller S, Stürzel CM, Kmiec D,
Conzelmann C, et al: IFITM proteins promote SARS-CoV-2 infection
and are targets for virus inhibition in vitro. Nat Commun.
12(4584)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shi G, Kenney AD, Kudryashova E, Zani A,
Zhang L, Lai KK, Hall-Stoodley L, Robinson RT, Kudryashov DS,
Compton AA and Yount JS: Opposing activities of IFITM proteins in
SARS-CoV-2 infection. EMBO J. 40(e106501)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang YS, Luo QL, Guan YG, Fan DY, Luan GM
and Jing A: HCMV infection and IFITM3 rs12252 are associated with
Rasmussen's encephalitis disease progression. Ann Clin Transl
Neurol. 8:558–570. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li M, Li YP, Deng HL, Wang MQ, Chen Y,
Zhang YF, Wang J and Dang SS: DNA methylation and SNP in IFITM3 are
correlated with hand, foot and mouth disease caused by enterovirus
71. Int J Infect Dis. 105:199–208. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xu-Yang Z, Pei-Yu B, Chuan-Tao Y, Wei Y,
Hong-Wei M, Kang T, Chun-Mei Z, Ying-Feng L, Xin W, Ping-Zhong W,
et al: Interferon-induced transmembrane protein 3 inhibits Hantaan
virus infection, and its single nucleotide polymorphism rs12252
influences the severity of hemorrhagic fever with renal syndrome.
Front Immunol. 7(535)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang Y, Makvandi-Nejad S, Qin L, Zhao Y,
Zhang T, Wang L, Repapi E, Taylor S, McMichael A, Li N, et al:
Interferon-induced transmembrane protein-3 rs12252-C is associated
with rapid progression of acute HIV-1 infection in Chinese MSM
cohort. AIDS. 29:889–894. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Makvandi-Nejad S, Laurenson-Schafer H,
Wang L, Wellington D, Zhao Y, Jin B, Qin L, Kite K, Moghadam HK,
Song C, et al: Lack of truncated IFITM3 transcripts in cells
homozygous for the rs12252-C variant that is associated with severe
influenza infection. J Infect Dis. 217:257–262. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Neagu M, Calina D, Docea AO, Constantin C,
Filippini T, Vinceti M, Drakoulis N, Poulas K, Nikolouzakis TK,
Spandidos DA and Tsatsakis A: Back to basics in COVID-19: Antigens
and antibodies-completing the puzzle. J Cell Mol Med. 25:4523–4533.
2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Petrakis D, Nikolouzakis TK, Karzi V,
Vardavas AI, Vardavas CI and Tsatsakis A: The growing anthropogenic
immune deficit and the COVID-19 pandemic. Public Health Toxicol.
1:1–5. 2021.
|
|
30
|
Tsatsakis A, Vakonaki E, Tzatzarakis M,
Flamourakis M, Nikolouzakis TK, Poulas K, Papazoglou G, Hatzidaki
E, Papanikolaou NC, Drakoulis N, et al: Immune response (IgG)
following full inoculation with BNT162b2 COVID-19 mRNA among
healthcare professionals. Int J Mol Med. 48(200)2021.PubMed/NCBI View Article : Google Scholar
|
